Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. ETF
  3. TECX
TECX logo

TECX

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewTechnicalNews
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

TECX News

Tectonic Therapeutics Reports 2025 Financial Results and Pipeline Updates

Feb 27 2026NASDAQ.COM

Tectonic Therapeutics Q4 Earnings Beat Expectations

Feb 26 2026seekingalpha

Tectonic Therapeutics to Host TX2100 Virtual KOL Event

Feb 11 2026Yahoo Finance

Credo Technology Raises Revenue Guidance Significantly

Feb 10 2026Benzinga

TECX, GKOS, GH, ALGN, NMRA Experience After-Hours Surge Following Clinical Data and Earnings Reports

Oct 30 2025NASDAQ.COM

Three Biotech Stocks Rated 'Strong Buy' by Analysts with Potential Upside Exceeding 300%

Sep 05 2025TipRanks

Oppenheimer Begins Coverage of Tectonic Therapeutics with Outperform Rating and Sets Price Target at $80

Sep 03 2025Benzinga

Tectonic Therapeutics to Attend Investor Conferences in September

Aug 28 2025Newsfilter

Tectonic (TECX) Q2 R&D Soars 142%

Aug 08 2025NASDAQ.COM

Tectonic Therapeutic Joins Russell 3000® Index

Jun 30 2025Newsfilter

Raymond James Reinstates Outperform on Tectonic Therapeutic, Announces $76 Price Target

Jun 11 2025Benzinga

LifeSci Capital Initiates Coverage of Tectonic Therapeutic (TECX) with Outperform Recommendation

Jun 07 2025NASDAQ.COM

Tectonic Therapeutic Announces First Quarter 2025 Financial Results and Recent Business Highlights

May 08 2025Yahoo Finance

This Dycom Industries Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday

Apr 21 2025Benzinga

Mizuho Initiates Coverage On Tectonic Therapeutic with Outperform Rating, Announces Price Target of $51

Apr 21 2025Benzinga

Tectonic Therapeutic to Present Phase 1b Data for TX45 at European Society of Cardiology Heart Failure 2025

Apr 15 2025Newsfilter